About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, February 24th, 2016

The QualityStocks
Daily Stock List


HedgePath Pharmaceuticals, Inc. (HPPI)

We are highlighting HedgePath Pharmaceuticals, Inc. (HPPI), here at the QualityStocks Daily Newsletter.

HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company whose shares trade on the OTC Markets Group’s OTCQB. The Company discovers, develops and plans to commercialize pioneering therapeutics for patients with cancer. It is looking to repurpose the Food and Drug Administration (FDA) approved antifungal pharmaceutical itraconazole as a potential treatment for cancer. Established in 1992, HedgePath Pharmaceuticals is based in Tampa, Florida. It also has an office in San Diego, California.

The Company is the exclusive U.S. licensee of a patented formulation of itraconazole, named SUBA-Itraconazole. Clinical studies have shown it to have greater bioavailability than generic itraconazole.

The Hedgehog signaling pathway is a major regulator of cellular processes in vertebrates. This includes cell differentiation, tissue polarity and cell proliferation. HedgePath Pharmaceuticals believes (based on published research) that inhibiting the Hedgehog pathway could delay or possibly prevent the development of certain cancers in humans.

Taking advantage of research undertaken by key investigators in the field, HedgePath Pharmaceuticals’ plan is to explore the effectiveness of SUBA-Itraconazole as an anti-cancer agent and to pursue its potential commercialization.

HedgePath Pharmaceuticals previously announced that initial patients received base-line screening and the first of those patients commenced dosing in the Company’s Phase II(b) clinical trial examining SUBA™ Itraconazole Capsules as a potential therapy for basal cell carcinoma (BCC) in patients with basal cell carcinoma nevus syndrome (BCCNS) - also named Gorlin's Syndrome.

The Company also earlier announced that it entered into a sublicense with its commercial partner and licensor Mayne Pharma. This is for exclusive rights in the United States to two additional patents pertaining to the use of itraconazole for the treatment of cancer, namely US patent No 8,980,930 entitled “Angiogenesis Inhibitors”, issued on March 17, 2015, and US patent No 8,653,083 entitled “Hedgehog Pathway Antagonists to Treat Disease”, issued on February 18, 2014.

HedgePath Pharmaceuticals, Inc. (HPPI), closed Wednesday's trading session at $0.10, even for the day. The average volume for the last 60 days is 7,261 and the stock's 52-week low/high is $0.07/$0.2998.

Gilla, Inc. (GLLA)

SmallCapVoice, SmallCapFinancialWire, and Greenbackers reported earlier on Gilla, Inc. (GLLA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Gilla, Inc. manufactures, markets, and distributes E-liquid, the liquid used in vaporizers, and E-cigarettes, and other vaping hardware and accessories. E-cigarettes are increasingly being considered as an alternative to conventional tobacco cigarettes. They provide authentic smoking pleasure and do not burn tobacco. Nevertheless, they are not smoking cessation devices.

The Company’s product portfolio includes Craft Vapes, Craft Clouds, Miss Pennysworth's Elixirs, The Mad Alchemist and Replicant E-liquid brands. Gilla is headquartered in Daytona Beach, Florida. It also has an office in Toronto, Ontario. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Gilla’s goal is to become a worldwide leader in the manufacturing and distribution of E-liquid brands and proprietary recipes for the vapor industry. E-cigarettes and vaporizers are replacements for traditional cigarettes. E-cigarettes produce no offensive smells or second hand smoke. E-cigarettes allow smokers to reproduce the smoking experience. E-liquid is heated by the atomizer to deliver the sensation and taste of smoking.

Gilla has a two-branch business model. One is Custom E-liquid Manufacturing. This includes private label solutions, E-Liquid flavoring and fulfilment services. The other is Marketing & Online Services. This includes branding, marketing, sales support, as well as e-commerce solutions.

Last month, Gilla announced that it established Gilla Europe Kft., and hired a top E-cig sales and distribution management team. The move brings on board a foremost E-cig distribution platform accessing greater than 25 European countries and encompassing more than 30 languages.

In addition, Gilla agreed to take over the office space for the 20-plus-person team in Budapest, Hungary and also the logistics and warehousing services based in Slovakia. The distribution platform was providing exclusive services to a top cig-a-like E-cig brand and had built its sales to a peak level of in excess of $3 million annually.

Mr. J. Graham Simmonds, Chairman and Chief Executive Officer of Gilla, said, "This is another great opportunity for Gilla and the timing could not be better. As we have successfully acquired and developed our portfolio of premium E-liquid brands, we will now aggressively pursue building out the demand side of the business.”

Gilla, Inc. (GLLA), closed Wednesday's trading session at $0.13, even for the day, on 42,535 volume with 6 trades. The average volume for the last 60 days is 28,478 and the stock's 52-week low/high is $0.05/$0.20.

Viveve Medical, Inc. (VIVMF)

Microcapmillionaires and Stock News Now reported earlier on Viveve Medical, Inc. (VIVMF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Viveve Medical, Inc. is an organization concentrating on women's health. Viveve, Inc. is the operating subsidiary of Viveve Medical. Viveve, Inc. is a women's health company dedicated to advancing new solutions to improve women's overall well-being and quality of life. Viveve’s aim is to increase awareness of the Viveve Treatment option and to stimulate the conversation between women and their doctors concerning vaginal laxity and sexual health. Viveve is headquartered in Sunnyvale, California.

The Company provides an office-based non-surgical, painless medical treatment for treating vaginal laxity. A physician performs the procedure using the Viveve System. This system works by cooling and gently heating vaginal tissue. Viveve states that his treatment option can increase feelings of vaginal tightness and improve sexual satisfaction.

The Company's lead product is the internationally patented Viveve System. This is a non-surgical, non-ablative medical device, which remodels collagen and restores tissue with only one treatment session. At present, the Viveve System is not available for sale in the United States. It has received regulatory approval in Europe, Canada and Hong Kong. It is available through physician import license in Japan.

The Viveve System treats the condition of vaginal laxity, the result of the over-stretching of tissue during childbirth, which can result in a decrease in physical sensation and sexual satisfaction. Physician surveys show that vaginal laxity is the number one post-delivery physical change for women.

Vaginal laxity is more widespread than weight gain, urinary incontinence, or stretch marks. The Viveve Treatment employs patented, reverse-thermal gradient radiofrequency technology to tighten vaginal tissue in one 30-minute out-patient treatment in a physician's office.

In January, Viveve Medical announced the expansion of its commercial partnership with Dynamic Medical Technologies, Inc. (DMT). DMT is a specialized and eminent supplier of medical devices into certain Asian Pacific countries. The exclusive, 3-year distribution partnership expands the Company's worldwide presence and includes minimum purchase requirements of 47 Viveve Systems in 2016, 75 in 2017, as well as 109 in 2018.

Viveve Medical, Inc. (VIVMF), closed Wednesday's trading session at $0.87, even for the day. The average volume for the last 60 days is 10,320 and the stock's 52-week low/high is $0.30/$1.15.

Meridian Waste Solutions, Inc. (MRDN)

Today we choose to report on Meridian Waste Solutions, Inc. (MRDN), here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, Meridian Waste Solutions, Inc. centers on solutions in the waste industry. At present, it operates in St. Louis, Missouri as Meridian Waste Services, Christian Environmental Services and Meridian Waste Solutions, which serves more than 65,000 residential, commercial and temporary customers in the St. Louis market. To date, Meridian Waste Services has helped in recycling more than 20,000 tons of waste in the St. Louis area.

Meridian Waste Solutions has its corporate head office in Milton, Georgia. The Company operates in the Diversified Services industry (Sub Industry: Management Services) in the Services sector.

Meridian’s waste management division provides turnkey solid waste removal and environmental management services. It provides these to municipalities, individuals, as well as companies. Meridian Waste Solutions services include Commercial, Residential, Recycling, Roll-offs, and Special Events.

The Company operates three transfer stations and one municipal solid waste landfill, in addition to a fleet of commercial, residential and temporary roll off trucks. Meridian Waste Solutions is focusing on providing premier customer service in the form of short-term and long-term contracts.

Recently, Meridian Waste Solutions announced that as of December 22, 2015 the Company secured from Goldman Sachs Specialty Lending Group, L.P. a $55 million credit facility, with $40 million of this amount funded at closing (the Financing) and, at the same time with the Financing, it closed on two strategic acquisitions (the Acquisitions). The Financing and the Acquisitions permit Meridian to become a fully integrated waste management operation with significant hauling assets, transfer stations and a Municipal Solid Waste (MSW) landfill in the St. Louis market.

Yesterday, Meridian Waste Solutions’ Board of Directors announced the appointment of Mr. Walter H. Hall as a Director of the firm, effective immediately. Mr. Hall's appointment expands the Board of Directors to two. Joining the Chairman & Chief Executive Officer, Mr. Jeff Cosman, Mr. Hall is the first director appointed to the Board with a number of other appointments to follow. Mr. Hall will be a member of the Company’s Evaluation, Executive and Marketing Committees.

Meridian Waste Solutions, Inc. (MRDN), closed Wednesday's trading session at $1.70, even for the day, on 795 volume with 3 trades. The average volume for the last 60 days is 3,175 and the stock's 52-week low/high is $0.295/$2.00.

Mobiquity Technologies, Inc. (MOBQ)

SmallCapVoice, PennyStocks24, PennyPickAlerts, Penny Stock Circle, 1-2-3 Stock Alerts, and StockMister reported earlier on Mobiquity Technologies, Inc. (MOBQ), and we choose to report on the Company today, here at the QualityStocks Daily Newsletter.

Mobiquity Technologies, Inc. operates a national location-based mobile advertising network. This network has developed a consumer-focused proximity network. Mobiquity's integrated suite of innovative location-based mobile advertising technologies enables its clients to execute more personalized and contextually relevant experiences. This drives brand awareness and incremental revenue. Mobiquity Networks is a wholly-owned subsidiary of Mobiquity Technologies. Mobiquity Technologies is based in Garden City, New York.

The Company operates a nationwide location‐based mobile advertising network of beacons. It has exclusive agreements in 475-plus first-rate United States shopping malls, reaching over 400 million shoppers each month.

Mobiquity Technologies is continuing to work to expand its location-based mobile advertising solutions to create "smart malls" in retail destinations across the United States using Bluetooth-enabled iBeacon technology. Its Mobiquity Networks has the largest shopping mall-based beacon mobile advertising network in the nation. The network includes such iconic properties as Roosevelt Field Mall in New York, King of Prussia Mall in Pennsylvania, Sawgrass Mills Mall in Florida, The Galleria in Texas, and Brea Mall in California.

By way of its subsidiaries, Mobiquity Technologies provides brand marketing, advanced integrated marketing platforms, mobile marketing, social networks, Website development, and digital media solutions. The Company provides brand analysis and development, Website analysis and development, database analysis and building, and integrated marketing campaigns utilizing direct mail, email marketing, mobile marketing, promotional products, and other mediums.

Moreover, Mobiquity Technologies provides a proprietary Web development platform and delivers a content management system, which puts content control back into the clients’ hands. Furthermore, the Company provides hyper-local mobile marketing solutions. This includes a location-based marketing tool that delivers digital content to Bluetooth or Wi-Fi enabled devices.

Together with the Company’s integrated suite of revolutionary location-based mobile advertising technologies, retail and entertainment brands can execute personalized and contextually relevant mobile ad experiences, building brand awareness and incremental revenue.

Last week, Company subsidiary Mobiquity Networks announced that its beacons are now compliant with Google’s latest Eddystone protocol for Chrome. Mobiquity Networks’ beacons will be able to broadcast in iBeacon (Apple) and Eddystone (Google) at the same time.

Yesterday, Mobiquity Networks announced results from a series of paid holiday season campaigns, which exceeded expectations. Over the most recent holiday shopping season it executed many mobile campaigns for leading national retailers and several new movie releases.

The design of the campaigns was to influence in-mall shopper traffic and to use the inventive traffic measurement capability of the Mobiquity network to directly quantify campaign success. Success in this case was defined as “driving the customer to the store” according to Mobiquity Networks Co-Chief Executive Officer, Mr. Dean Julia.

Mobiquity Technologies, Inc. (MOBQ), closed Wednesday's trading session at $0.17, down 5.56%, on 18,900 volume with 6 trades. The average volume for the last 60 days is 58,365 and the stock's 52-week low/high is $0.10/$0.39.


The QualityStocks
Company Corner


Oakridge Global Energy Solutions, Inc. (OGES)

The QualityStocks Daily Newsletter would like to spotlight Oakridge Global Energy Solutions, Inc. (OGES). Today, On the Move Systems, Inc. closed trading at $0.67, up 6.35%, on 133,287 volume with 71 trades. The stock’s average daily volume over the past 60 days is 20,599, and its 52-week low/high is $0.20/$2.40.

Oakridge Global Energy Solutions, Inc. is excited to announce that it will be supplying batteries to Freedom Trucking in Minnesota. Freedom Trucking has developed a fully electric interstate truck propulsion system that will immediately enable interstate trucks with a gross vehicle weight of 80,000 pounds to travel more than 400 miles. By utilizing a proprietary logistical system, powered by specially designed Oakridge battery systems, Freedom Trucking can now begin to utilize its revolutionary fully electric interstate trucks in the interstate logistics industry to move product from Chicago to Minneapolis on a daily basis commencing in the last half of 2016.

Oakridge Global Energy Solutions, Inc. (OGES) is an integrated energy storage solutions company focused on the design, development and manufacture of high-quality cells, batteries and power systems. The company's innovative 'Made in the U.S.A.' product line includes multiple lithium-ion technologies and form factors that are optimized to address three high-demand target markets – including stationary and grid storage; motive applications, such as electric and hybrid electric fleet vehicles; and specialty applications, such as military, aerospace, marine, medical and telecom backup.

Through a recent restructuring of its operations, Oakridge strategically positioned itself to expand its market reach moving forward. The company currently owns and operates two manufacturing facilities in Melbourne, Florida, which play an instrumental role in its efforts to meet the growing demand for its cutting-edge large format Pro Series golf car batteries and its small format Patriot Series RC batteries. These operations also allow Oakridge to bring stable employment opportunities back to the U.S., effectively highlighting its tireless commitment to the revitalization of the country's manufacturing industry.

The company also maintains a presence on the international stage through its recently formed subsidiary, Oakridge Global Energy Solutions Limited, Hong Kong. This subsidiary, which is expected to serve as the foundation for Oakridge's sales efforts throughout the Asia-Pacific region, was created primarily to address the tremendous international demand for its revolutionary stored energy solutions. The company also maintains a substantial interest in Leclanche S.A., a Swiss developer and manufacturer of large-sized lithium-ion batteries that was originally founded in 1909.

Oakridge has indicated plans to expand its presence in a collection of markets throughout Europe and Asia as it continues to build upon its established product development and manufacturing infrastructure. The company will lean on the expertise of its proven management team – which includes well over a century of combined industry experience – as it looks to increase its share of the $12 billion domestic battery manufacturing industry. Disclaimer

Oakridge Global Energy Solutions, Inc. Company Blog

Oakridge Global Energy Solutions, Inc. News:

Oakridge Supplying Battery Systems to Fully Electric Interstate Trucking in the USA

Oakridge Powered MARTAC Demonstration Huge Success

Oakridge Announces New Corporate Image, Branding and Media Communications Tools as it Enters Full-Scale Production for 2016

GTX Corp. (GTXO)

The QualityStocks Daily Newsletter would like to spotlight GTX Corp. (GTXO). Today, GTX Corp. closed trading at $0.011, up 22.91%, on 123,983 volume with 5 trades. The stock’s average daily volume over the past 60 days is 421,447, and its 52-week low/high is $0.0052/$0.023.

GTX Corp. (GTXO), through its robust IoT enterprise monitoring platform and licensing, subscription recurring revenue business model, offers a complete end-to-end solution backed by an extensive portfolio of patents with filing dates going back as early as 2002, patents pending, registered trademarks, copy rights and URLs. GTX was featured in a 38-page research piece outlining the value proposition of the company's IP portfolio, and was also published in a SeeThruEquity research report discussing the value of the company's IP.

GTX has established a growing global distribution network with partners in more than 20 countries, and has garnered millions of dollars' worth of free media with coverage on CNN, Good Morning America, The Doctors, Fox News, Discovery Channel, ABC, NBC, CBS, The New York Times, LA Times, U.S.A. Today, the LA Business Journal, AARP and hundreds of other television, radio, magazine and newspaper media outlets across the globe.

The company's flagship, patented GPS SmartSoles were recently showcased in Munich at the Telefonica Digital Innovation Day 2015; was featured in AARP's 2015 technology gear guide; and came in second place, with Microsoft finishing first and Samsung taking third, in the 2015 Wearables, Health, Fitness & Wellness category at CTIA's Hot for the Holidays Awards competition.

As GTX continues to expand its brand awareness and distribution channels both domestically and internationally, in parallel it also plans to introduce new products with an emphasis on e-health and wellness. Corporate strategies are guided by a visionary management team with the insight and experience needed to navigate the plentiful opportunities and potential market share in the emerging multibillion IoT and Wearable Tech industries.

"With approximately 2% of the population having been diagnosed with Alzheimer's, dementia, autism, TBI or some other cognitive disorder which may lead to wandering due to memory loss, GTX plays a vital role in the safety, security and recovery of these individuals and their caregivers." --- Patrick Bertagna GTX Corp CEO. Disclaimer

GTX Corp. Company Blog

GTX Corp. News:

GTX Corp to Present at 2nd Annual Innovations Investor Conference and Announces Date of Shareholder Meeting

GPS SmartSoles Launch in Latin America

GTX Corp Engages Maxim Group LLC to Provide Strategic Advisory Services

Avant Diagnostics, Inc. (AVDX)

The QualityStocks Daily Newsletter would like to spotlight Avant Diagnostics, Inc. (AVDX). Today, Avant Diagnostics, Inc. closed trading at $0.4175, up 12.84%, on 1,570 volume with 3 trades. The stock’s average daily volume over the past 60 days is 1,778, and its 52-week low/high is $0.20/$1.95.

Avant Diagnostics, Inc. (AVDX) is a medical diagnostic technology company that specializes in large panel biomarker screening. The company's first test, OvaDx®, is a sophisticated microarray-based test designed to detect pre-symptomatic ovarian cancer by measuring the activation of the immune system in blood samples in response to early stage ovarian tumor cell development.

In clinical development, OvaDx has indicated high sensitivity and specificity for all types and stages of ovarian cancer, including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous and ovarian adenocarcinoma. Upon FDA approval, Avant plans to offer its diagnostic product as an elective test for women seeking greater wellness, as well as those in the elevated risk category for ovarian cancer.

OvaDx is also expected to be used by doctors to advance the forefront of ovarian cancer treatment, promoting the utilization of improved surgical options and more effective chemotherapies by serving as a supplement to existing tests, such as CA-125, OVA1® and transvaginal ultrasound. In this way, Avant's innovative product will promote earlier diagnoses and, as a result, improved survival rates for patients with ovarian cancer.

As it continues to seek FDA approval for its groundbreaking diagnostic technology, Avant is poised to promote considerable growth in the ovarian cancer market, addressing what is currently the most deadly cancer of the female reproductive system. The company will lean on the industry experience of its management team in order to continue positioning itself for long-term success in the medical diagnostic market. Disclaimer

Avant Diagnostics, Inc. Company Blog

Avant Diagnostics, Inc. News:

Avant Diagnostics, Inc. To Present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference at the Ritz in South Beach on Feb. 22, 2016

Amarantus Enters into Letter of Intent to Merge Diagnostics Business Unit into Avant Diagnostics

Avant Diagnostics to Attend 12th Annual Noble Capital Markets Conference

Immune Therapeutics, Inc. (IMUN)

The QualityStocks Daily Newsletter would like to spotlight Immune Therapeutics, Inc. (IMUN). Today, Immune Therapeutics, Inc. closed trading at $0.176, up 0.57%, on 175,242 volume with 32 trades. The stock’s average daily volume over the past 60 days is 135,677, and its 52-week low/high is $0.045/$0.36.

Immune Therapeutics, Inc. (IMUN) is a biotechnology company applying its patented immunotherapy to combat chronic, life-threatening diseases that affect persons around the world. Building on the power of the body's natural immune system, the company's pipeline of products and immunotherapy technologies are designed to enhance treatment of cancer, infections such as HIV/AIDS, chronic inflammatory diseases, and a variety of autoimmune diseases.

Immune Therapeutics' most advanced clinical programs involve immunotherapy with met-enkephalin (MENK) (sometimes referred to as opioid growth factor) and its low dose naltrexone product (LDN), internationally known as Lodonal™, both of which have been shown to stimulate immune systems even in patients with advanced cancer.

Additionally, Immune Therapeutics is pursuing additional investigations for MENK and LDN as viable treatments for autoimmune conditions such as rheumatoid arthritis and multiple sclerosis; as an adjunct in cancer patients undergoing chemotherapy, radiation treatments or surgery; and as a complement to antibiotics in the treatment of a variety of infectious diseases, including patients with HIV/AIDS, in combination with retroviral drug therapy.

Immune Therapeutics and partners AHAR Pharma and GB Pharma Holdings recently completed a bridging trial to determine the safety and efficacy of LDN in patients with HIV, and have submitted data in connection with the filing of its New Drug Application for LDN with The National Agency for Food and Drug Administration and Control, (NAFDAC) of Nigeria. Disclaimer

Immune Therapeutics, Inc. Company Blog

Immune Therapeutics, Inc. News:

Immune Therapeutics, Inc to Present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference at the Ritz in South Beach on Feb. 22, 2016

SeeThruEquity Initiates Coverage on Immune Therapeutics, Inc. with a Price Target of $0.61

Immune Therapeutics, Inc. Announced the Completion of the Bridging Trial

View Systems, Inc. (VSYM)

The QualityStocks Daily Newsletter would like to spotlight View Systems, Inc. (VSYM). Today, View Systems, Inc. closed trading at $0.0019, even for the day, on 100,550 volume with 3 trades. The stock’s average daily volume over the past 60 days is 613,841, and its 52-week low/high is $0.0011/$0.0151.

View Systems, Inc. (VSYM) is a leading security technology products company with “state-of-the-art” technological solutions for modern security problems. Targeting the challenging business opportunities in the opening decades of the 21st century and beyond, View Systems has solutions for law enforcement facilities such as correctional institutions as well as other government agencies, schools, courthouses, event and sports venues, the military and commercial businesses.

The senior management team is comprised of successful businessmen with decades of business and professional experience in the security industry. The approach used by View Systems utilizes the expertise of this team to provide innovative solutions to security problems with reliable “cutting edge” products in conjunction with client-oriented security consulting services.

The company’s flagship product, ViewScan, is an advanced walk-through Concealed Weapons Detection System (CWD) that greatly simplifies the process of discriminating suspicious items from harmless ones. The highly sensitive, completely passive sensor technology powering the system accurately detects the location and number of threat objects such as knives, guns and razor blades while ignoring personal artifacts like coins, keys and belt buckles. A portable version of this system has only a fifteen minute setup time using only a screwdriver and it easily fits inside a golf size case.

Experts say the security industry has been the fastest-growing sector of the global economy during the past decade. Today, it is conservatively estimated to be a $100 billion-a-year industry and growing. As the business environment continues to get more complex, especially in foreign markets, View Systems is strategically positioned to capitalize on unsurpassed opportunity. Disclaimer

View Systems, Inc. Company Blog

View Systems, Inc. News:

View Systems, Inc. (VSYM) to Acquire Y.M. Advantage, Inc.

View Systems in Discussions With Three M&A Candidates and Reviewing Letter of Intent

View Systems, Inc. Files for Patent, Begins Manufacturing of Enhanced ViewScan Product


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters








By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251